Viviane Bertrand

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian, Jean‐Michel Vallat, Laurent Magy et al. · Orphanet Journal of Rare Diseases · 2014 · 124 citations · Full text

Medicine, Neurology, Pharmacology +15

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

Ilya Chumakov, Aude Milet, Nathalie Cholet et al. · Orphanet Journal of Rare Diseases · 2014 · 105 citations · Full text

Medicine, Neurology, Pharmacology +15

Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis

Rosine Guimbaud, Viviane Bertrand, Laurence Chauvelot‐Moachon et al. · The American Journal of Gastroenterology · 1998 · 84 citations

Veterinary Medicine, Immunology, Pathobiology +17

Increase in tumor necrosis factor‐<i>α</i> production linked to the toxicity of indomethacin for the rat small intestine

Viviane Bertrand, Rosine Guimbaud, M Tulliez et al. · British Journal of Pharmacology · 1998 · 82 citations · Full text

Veterinary Medicine, Pharmacology, Toxicology +17

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy

Ilya Chumakov, Serguei Nabirotchkin, Nathalie Cholet et al. · Scientific Reports · 2015 · 66 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17